Zhou Yumei, Chen Xianfeng, Chen Jun, Kendrick Conner D, Ramanathan Ramesh K, Graham Rondell P, Kossick Kimberlee F, Boardman Lisa A, Barrett Michael T
Department of Research, Mayo Clinic in Arizona, Scottsdale, AZ, USA.
Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 55905, USA.
Sci Rep. 2024 Apr 23;14(1):9368. doi: 10.1038/s41598-024-59398-5.
Although colorectal cancer (CRC) remains the second leading cause of cancer-related death in the United States, the overall incidence and mortality from the disease have declined in recent decades. In contrast, there has been a steady increase in the incidence of CRC in individuals under 50 years of age. Hereditary syndromes contribute disproportionately to early onset CRC (EOCRC). These include microsatellite instability high (MSI+) tumors arising in patients with Lynch Syndrome. However, most EOCRCs are not associated with familial syndromes or MSI+ genotypes. Comprehensive genomic profiling has provided the basis of improved more personalized treatments for older CRC patients. However, less is known about the basis of sporadic EOCRC. To define the genomic landscape of EOCRC we used DNA content flow sorting to isolate diploid and aneuploid tumor fractions from 21 non-hereditary cases. We then generated whole exome mutational profiles for each case and whole genome copy number, telomere length, and EGFR immunohistochemistry (IHC) analyses on subsets of samples. These results discriminate the molecular features of diploid and aneuploid EOCRC and provide a basis for larger population-based studies and the development of effective strategies to monitor and treat this emerging disease.
尽管结直肠癌(CRC)仍是美国癌症相关死亡的第二大主要原因,但近几十年来,该疾病的总体发病率和死亡率有所下降。相比之下,50岁以下个体的结直肠癌发病率却在稳步上升。遗传性综合征在早发性结直肠癌(EOCRC)中所占比例过高。这些包括林奇综合征患者中出现的微卫星高度不稳定(MSI+)肿瘤。然而,大多数早发性结直肠癌与家族综合征或MSI+基因型无关。全面的基因组分析为改善老年结直肠癌患者的个性化治疗提供了依据。然而,对于散发性早发性结直肠癌的发病基础了解较少。为了确定早发性结直肠癌的基因组特征,我们使用DNA含量流式分选技术从21例非遗传性病例中分离出二倍体和非整倍体肿瘤组分。然后,我们为每个病例生成了全外显子组突变图谱,并对部分样本进行了全基因组拷贝数、端粒长度和表皮生长因子受体免疫组化(IHC)分析。这些结果区分了二倍体和非整倍体早发性结直肠癌的分子特征,为开展更大规模的基于人群的研究以及制定监测和治疗这种新出现疾病的有效策略提供了依据。